Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Borregaard ASA ( (GB:0QB7) ) has provided an announcement.
Borregaard reported first-quarter 2026 operating revenues of NOK 2,005 million, slightly down from a year earlier, with EBITDA declining to NOK 428 million amid increased cost pressures. Profit before tax fell to NOK 230 million and earnings per share to NOK 1.82, reflecting softer performance in key divisions despite stable currency effects.
In BioSolutions, lower sales volumes caused by supply chain delays, geopolitical uncertainty and customer destocking were partly offset by higher prices, while BioMaterials saw increased specialty cellulose deliveries but weaker prices and product mix. Fine Chemicals delivered stronger results on higher volumes and a favourable mix, and management said targeted measures are being implemented to counter continued cost pressure linked to geopolitical developments.
The most recent analyst rating on (GB:0QB7) stock is a Buy with a NOK192.00 price target. To see the full list of analyst forecasts on Borregaard ASA stock, see the GB:0QB7 Stock Forecast page.
More about Borregaard ASA
Borregaard ASA is a Norwegian specialty chemicals company that develops bio-based products derived mainly from wood, supplying segments such as BioSolutions, BioMaterials and Fine Chemicals. The group focuses on specialty cellulose, fine chemical intermediates and other high-value bioproducts, targeting industrial customers seeking sustainable alternatives to traditional petrochemical-based inputs.
Average Trading Volume: 129,765
Current Market Cap: NOK16.55B
Find detailed analytics on 0QB7 stock on TipRanks’ Stock Analysis page.